0000905718-21-000630.txt : 20210429
0000905718-21-000630.hdr.sgml : 20210429
20210429160602
ACCESSION NUMBER: 0000905718-21-000630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210429
FILED AS OF DATE: 20210429
DATE AS OF CHANGE: 20210429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Praill Anthony Scott
CENTRAL INDEX KEY: 0001332948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37823
FILM NUMBER: 21870486
MAIL ADDRESS:
STREET 1: 2001-889 HOMER STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6B 5S3
FORMER NAME:
FORMER CONFORMED NAME: Praill Scott
DATE OF NAME CHANGE: 20050713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kintara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001498382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990360497
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 350-4364
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130123
FORMER COMPANY:
FORMER CONFORMED NAME: Berry Only Inc.
DATE OF NAME CHANGE: 20100805
4
1
kintara_fm4apr292021.xml
X0306
4
2021-04-29
0
0001498382
Kintara Therapeutics, Inc.
KTRA
0001332948
Praill Anthony Scott
12707 HIGH BLUFF DR.
SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
Chief Financial Officer
Common Stock
2021-04-29
4
J
0
8
0
A
7548
D
Common Stock
2021-04-29
4
C
0
938
A
8486
D
Series B Convertible Preferred Stock
2021-04-29
4
C
0
3750
0
D
2016-04-29
Common Stock
938
0
D
The shares were issued as dividends to April 29, 2021 on the reporting person's shares of Series B Preferred Stock.
Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock.
Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00.
/s/ Anthony Scott Praill
2021-04-29